X0206 3 2025-03-04 0 0001894525 Apimeds Pharmaceuticals US, Inc. APUS 0002057997 Inscobee Inc. ROOM 613, DIGITAL-RO 130, 6F GEUMCHEON-GU SEOUL M5 08580 KOREA, REPUBLIC OF 0 0 1 0 Common Stock, par value $0.01 per share 1484615 D Common Stock, par value $0.01 per share 4134619 I By Apimeds Inc. The shares of common stock are owned directly by Apimeds Inc., which is a wholly owned subsidiary of the reporting person. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Exhibit List: Exhibit 24 - Power of Attorney /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact 2025-05-08